Study Title (official): CELLEBRATE: An Adaptive, Two Stage, Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence
Objective of the study (Lay terms): This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) compared to a placebo in the treatment of stress urinary incontinence (SUI) in adult female patients. Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.
Principal Investigator: Christopher Tarnay, MD
Department: UCLA Department of OBGYN
For enrollment or criteria information:
Please visit the UCLA Health Clinical Trials website, or you may call Ross Divinagracia, study coordinator, at 310-825-0580.
For additional information regarding inclusion and exclusion criteria >